A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

An investigation of borealpox cases in Alaska determined that the virus is likely being spread from small mammals like voles ...

A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...

Participants in a multidisciplinary comprehensive obesity care model had clinically meaningful weight loss and high obesity ...

Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular ...

A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

According to the American Academy of Family Physicians, approximately 60 million children and adolescents participate in ...

Use of GLP-1 receptor agonists was associated with a twofold higher risk for neovascular age-related macular degeneration ...

Switching from a higher to a lower-sodium dose of Xywav led to significant reductions in 24-hour blood pressure for ...

Oral semaglutide improved glycemic parameters and cardiovascular risk factors for adults with overweight or obesity, with ...

Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, spoke about the current treatment landscape for ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...